Skip to content

A clinical trial to study the effect of Roghan Malish in patients with joint pain

Evaluation of analgesic and anti- inflammatory activity of Roghan Malish in cases of Wajaul Mafasil (Arthralgia) ââ?¬â?? A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021805
Enrollment
50
Registered
2019-10-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M255- Pain in joint

Interventions

Intervention1: Roghan Malish: Local application of 2.5 ml Roghan Malish twice daily for 2 weeks. Selected cases will be advised to apply 2.5 ml Roghan Malish locally over the joint (5 ml if two joint

Sponsors

Central Council for Research in Unani Medicine CCRUM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either gender, between the age group of 18 to 60 years, having single/multisite peripheral joint pain with/without swelling, morning stiffness and limited motion

Exclusion criteria

Exclusion criteria: Patients below 18 years and above 60 years of age, patients with recent injury to the joint affected, Wound at the joint affected, Surgery on the Joint within last 6 months, Applying any topical medicine within a week, Taking intra-joint injections or corticosteroid drugs within three last months, Physiotherapy within last month or during study, Patients with hypersensitivity / allergy to Roghan Malish

Design outcomes

Primary

MeasureTime frame
50 % improvement in pain, swelling and morning stiffnessTimepoint: The outcome will be assessed at baseline and after 2 weeks of treatment.

Secondary

MeasureTime frame
Improved quality of lifeTimepoint: 14 days

Countries

India

Contacts

Public ContactNoman Anwar

Regional Research Institute of Unani Medicine

nanomananwar@gmail.com7358595174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026